-
Tourmaline Bio, Inc. (NASDAQ:TRML) Given Consensus Recommendation of "Buy" by Analysts
Source: Buzz FX / 16 Mar 2025 02:16:17 America/New_York
Tourmaline Bio, Inc. (NASDAQ:TRML) Given Consensus Recommendation of "Buy" by Analysts Written by MarketBeat March 16, 2025 Share Link copied to clipboard. Remove Ads Shares of Tourmaline Bio, Inc. ( NASDAQ:TRML - Get Free Report ) have bee
Read more...